Melinta Therapeutics Announces Appointment of Bruce L. Downey to Board of Directors

NEW HAVEN, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that the company has appointed Bruce L. Downey to its Board of Directors.